Puma Biotechnology | PBYI - Trade Debtors


Puma Biotechnology reported $28.1M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Alnylam Pharmaceuticals USD 912.74M 28.78M Jun/2026
Amgen USD 10.23B 1.09B Jun/2026
Biogen USD 1.79B 76.6M Mar/2026
BioMarin Pharmaceutical USD 1.06B 157.13M Jun/2026
Daiichi Sankyo JPY 676.92B 19.03B Jun/2026
Exelixis USD 322.21M 6.73M Jun/2026
Gilead Sciences USD 5.06B 314M Jun/2026
Glaxosmithkline GBP 10.49B 40.6M Mar/2026
Incyte USD 1.13B 73.7M Jun/2026
MacroGenics USD 10.42M 2.95M Mar/2026
Moderna USD 17M 54M Jun/2026
Novartis USD 9.85B 252M Jun/2026
Pfizer USD 16.19B 19M Jun/2026
PTC Therapeutics USD 219.92M 38.3M Mar/2026
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sangamo BioSciences USD 581K 110K Jun/2024
Sarepta Therapeutics USD 393.8M 154.11M Jun/2026
Takeda JPY 956.14B 79.79B Jun/2026
TG Therapeutics USD 401.56M 9.52M Jun/2026
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
Vanda Pharmaceuticals USD 47.1M 4.35M Dec/2024
Vertex Pharmaceuticals USD 2.13B 138.2M Jun/2026